Anal Fissure Among Survivors of COVID-19 Virus Infection.
1 other identifier
observational
176
1 country
1
Brief Summary
Background Anal fissure is one of the most common anorectal problems. After an outbreak of coronavirus disease (COVID-19) has rapidly spread from China to almost all over the world, it nearly affected all countries. In spite of its typical presentation in the form of fever, cough, myalgia, fatigue and pneumonia, other GIT manifestations were reported. We found some of COVID-19 survivors who had complained from anal fissure problem. The aim of this study was to report the prevalence of acute anal fissure among COVID-19 patients, its possible risk factors and outcome. Methods This is a retrospective cross-sectional study which was conducted over three months from the start of September 2020 to the end of November 2020 at Mansoura university isolation hospital, on COVID-19 patients' who were diagnosed with anal fissure. Those who survived and were discharged home safely were telephone called to pick up whether they suffered from any symptoms of anal pain, difficulty in defecation suggesting anal fissure, in order to identify their outcomes, the risk factors for anal fissure development and how they were managed. Results A total of 176 patients were enrolled in this study. Patients were categorized into two groups. The first group included patients who developed anal fissure (n=65) and the 2nd group included patients who did not develop anal fissure (n=111). No significant difference was noted in demographic data apart from the age which was younger in the fissure group. The incidence of anal fissure was 36.9% of total population. The majority of patients' anal fissure problem resolved spontaneously after patients improved from the COVID symptoms without receiving any treatment (43.1%). Conclusion Anal fissure is quite common problem after COVID-19. Young and middle age patients are more vulnerable to develop anal fissure after COVID-19 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 18, 2023
CompletedFirst Posted
Study publicly available on registry
February 21, 2023
CompletedFebruary 24, 2023
February 1, 2023
2 months
February 18, 2023
February 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of anal fissure among covid -19 survivors
how many patients developed anal fissure among total patients
6 months
Secondary Outcomes (1)
risk factors associated with development of anal fissure
6 months - 1year
Eligibility Criteria
All COVID-19 survivors who developed anal fissure
You may qualify if:
- Patients of both genders
- Aging between 20-70 years
- With or without associated co-morbidities
- Those who received treatment for COVID-19 infection, were discharged home safely, Those who presented with anal fissure during the follow up were included.
You may not qualify if:
- Patients who didn't experience anal pain or anal fissure,
- Patients who died were excluded from this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmad
Al Mansurah, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- consultant and lecturer of general surgery
Study Record Dates
First Submitted
February 18, 2023
First Posted
February 21, 2023
Study Start
September 1, 2020
Primary Completion
October 30, 2020
Study Completion
November 30, 2020
Last Updated
February 24, 2023
Record last verified: 2023-02